EGFR and neoplasm: How essential these interdependencies are is evident for a number of preclinical studies reporting enhanced tumor cell kill and radiochemosensitization when the epidermal growth factor receptor (EGFR) is inhibited simultaneously to β1 integrin [4, 13].